Patients and the ProPep AdvantageThe organizations listed below can help you learn more about cryotherapy, prostate cancer, treatments, and preventive measures. You will also find support groups to help you through your treatment journey.
American Cancer Society® (ACS) Man to Man Program 1-800-ACS-2345 (1-800-227-2345)
The ACS Man to Man program helps men cope with prostate cancer by offering community-based education and support for patients and their family members.
American Urological Association (AUA) Foundation 1-800-828-7866
The AUA Foundation provides research and education to those interested in learning more about urological diseases or disorders, such as prostate cancer.
CancerCare 1-800-813-HOPE (1-800-813-4673)
CancerCare offers free support, information, financial assistance, and practical help to people with cancer and their loved ones.
Centers for Disease Control and Prevention (CDC) 1-800-CDC-INFO (1-800-232-4636)
CDC provides men, doctors, and policymakers with the latest information about prostate cancer.
National Cancer Institute (NCI) 1-800-4-CANCER (1-800-422-6237)
Part of the National Institutes of Health, NCI supports research, education, and the spread of health information about cancer.
Prostate Cancer Institute (PCI)
The PCI offers information on treatment options for prostate cancer.
Prostate Conditions Education Council (PCEC) 1-866-477-6788
PCEC promotes early detection, research, education, and awareness for prostate cancer and all prostate conditions.
Us TOO International 1-800-80-USTOO (1-800-808-7866)
Us TOO International is a nonprofit prostate cancer education and support network of 325 support group chapters worldwide, providing men and their families with free information, materials, and peer-to-peer support so they can make informed choices on detection, treatment options, and coping with ongoing survivorship.
ZERO: The Project to End Prostate Cancer 1-888-245-9455
ZERO supports research to help end prostate cancer, conducts free screening tests, and helps educate patients, their families, and people at risk about prostate cancer and treatment.